Fingerprint
Dive into the research topics of 'EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT
Akil A. Merchant, Aparna Jorapur, Amy McManus, Ren Liu, Valery Krasnoperov, Parvesh Chaudhry, Mohan Singh, Lisa Harton, Mary Agajanian, Miriam Kim, Timothy J. Triche, Brian J. Druker, Jeffrey W. Tyner, Parkash S. Gill
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations